アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/18 | 1,348 | 1,353 | 1,328.5 | 1,352.5 | +25.5 | +1.9% | 3,358,000 |
2025/04/17 | 1,321 | 1,328 | 1,314 | 1,327 | +4.5 | +0.3% | 3,912,800 |
2025/04/16 | 1,330 | 1,334.5 | 1,314.5 | 1,322.5 | -14.5 | -1.1% | 4,777,600 |
2025/04/15 | 1,332 | 1,350 | 1,328 | 1,337 | +24 | +1.8% | 5,711,400 |
2025/04/14 | 1,290 | 1,322.5 | 1,290 | 1,313 | +43.5 | +3.4% | 5,497,800 |
2025/04/11 | 1,253.5 | 1,276.5 | 1,251.5 | 1,269.5 | -64 | -4.8% | 10,637,500 |
2025/04/10 | 1,350 | 1,361 | 1,320.5 | 1,333.5 | +76.5 | +6.1% | 10,732,500 |
2025/04/09 | 1,328 | 1,331.5 | 1,243.5 | 1,257 | -84 | -6.3% | 13,738,400 |
2025/04/08 | 1,329.5 | 1,344 | 1,315 | 1,341 | +39.5 | +3% | 9,629,900 |
2025/04/07 | 1,300 | 1,337 | 1,274 | 1,301.5 | -88.5 | -6.4% | 11,695,000 |
2025/04/04 | 1,372 | 1,408 | 1,372 | 1,390 | +14.5 | +1.1% | 10,137,500 |
2025/04/03 | 1,375 | 1,388.5 | 1,365 | 1,375.5 | -28.5 | -2% | 11,161,900 |
2025/04/02 | 1,451 | 1,457 | 1,403 | 1,404 | -57 | -3.9% | 8,677,000 |
2025/04/01 | 1,461 | 1,473 | 1,454.5 | 1,461 | +14.5 | +1% | 5,137,800 |
2025/03/31 | 1,461 | 1,464 | 1,441.5 | 1,446.5 | -31 | -2.1% | 7,584,800 |
2025/03/28 | 1,468 | 1,482.5 | 1,467 | 1,477.5 | -25 | -1.7% | 7,099,200 |
2025/03/27 | 1,492 | 1,504 | 1,488.5 | 1,502.5 | +6.5 | +0.4% | 8,775,800 |
2025/03/26 | 1,510 | 1,512.5 | 1,490.5 | 1,496 | -4 | -0.3% | 6,444,400 |
2025/03/25 | 1,502 | 1,510 | 1,493.5 | 1,500 | -2 | -0.1% | 5,859,900 |
2025/03/24 | 1,506 | 1,512.5 | 1,502 | 1,502 | +8 | +0.5% | 5,173,300 |
2025/03/21 | 1,475 | 1,509 | 1,469.5 | 1,494 | +0.5 | ±0% | 13,285,100 |
2025/03/19 | 1,485 | 1,501 | 1,485 | 1,493.5 | +9.5 | +0.6% | 6,940,500 |
2025/03/18 | 1,492 | 1,495 | 1,484 | 1,484 | +4 | +0.3% | 5,453,700 |
2025/03/17 | 1,473.5 | 1,486 | 1,467 | 1,480 | +12 | +0.8% | 3,775,200 |
2025/03/14 | 1,446 | 1,472.5 | 1,446 | 1,468 | +9.5 | +0.7% | 6,953,100 |
2025/03/13 | 1,453 | 1,462.5 | 1,450 | 1,458.5 | +0.5 | ±0% | 4,370,200 |
2025/03/12 | 1,445.5 | 1,458 | 1,435 | 1,458 | +12 | +0.8% | 6,420,800 |
2025/03/11 | 1,455 | 1,463.5 | 1,443.5 | 1,446 | -14 | -1% | 8,560,400 |
2025/03/10 | 1,460 | 1,471 | 1,459 | 1,460 | +3.5 | +0.2% | 4,442,200 |
2025/03/07 | 1,458.5 | 1,468 | 1,452.5 | 1,456.5 | -15.5 | -1.1% | 7,105,700 |
2025/03/06 | 1,476 | 1,492 | 1,470.5 | 1,472 | +2 | +0.1% | 5,535,700 |
2025/03/05 | 1,457.5 | 1,484.5 | 1,454 | 1,470 | +12.5 | +0.9% | 6,518,800 |
2025/03/04 | 1,462.5 | 1,476.5 | 1,455 | 1,457.5 | -3.5 | -0.2% | 7,507,200 |
2025/03/03 | 1,470.5 | 1,474.5 | 1,455 | 1,461 | +7 | +0.5% | 4,600,600 |
2025/02/28 | 1,474.5 | 1,486 | 1,447 | 1,454 | -25 | -1.7% | 10,190,200 |
2025/02/27 | 1,487 | 1,500 | 1,477 | 1,479 | -10 | -0.7% | 4,382,200 |
2025/02/26 | 1,504 | 1,504.5 | 1,488.5 | 1,489 | -5.5 | -0.4% | 5,026,000 |
2025/02/25 | 1,466 | 1,498 | 1,466 | 1,494.5 | +29 | +2% | 5,199,200 |
2025/02/21 | 1,458.5 | 1,474 | 1,458.5 | 1,465.5 | +12 | +0.8% | 3,289,500 |
2025/02/20 | 1,455 | 1,467.5 | 1,444 | 1,453.5 | -9.5 | -0.6% | 5,126,100 |
2025/02/19 | 1,467.5 | 1,472.5 | 1,456.5 | 1,463 | -13 | -0.9% | 4,649,800 |
2025/02/18 | 1,476 | 1,486.5 | 1,473 | 1,476 | -1 | -0.1% | 3,024,700 |
2025/02/17 | 1,481 | 1,489.5 | 1,476 | 1,477 | -11.5 | -0.8% | 3,607,900 |
2025/02/14 | 1,502.5 | 1,517.5 | 1,477 | 1,488.5 | -5.5 | -0.4% | 9,077,600 |
2025/02/13 | 1,478.5 | 1,510 | 1,474.5 | 1,494 | +45.5 | +3.1% | 8,845,200 |
2025/02/12 | 1,447.5 | 1,512 | 1,418.5 | 1,448.5 | -4.5 | -0.3% | 20,083,500 |
2025/02/10 | 1,440 | 1,462 | 1,428.5 | 1,453 | +19.5 | +1.4% | 6,959,000 |
2025/02/07 | 1,427 | 1,444 | 1,422.5 | 1,433.5 | +0.5 | ±0% | 4,386,300 |
2025/02/06 | 1,431.5 | 1,445 | 1,426 | 1,433 | +5.5 | +0.4% | 5,584,000 |
2025/02/05 | 1,470.5 | 1,472.5 | 1,415 | 1,427.5 | -57.5 | -3.9% | 12,620,400 |
1~
50
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 135,200円 | +18.5% | -96.0% | 5.47% | 172.89倍 | 1.58倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
第一三共 | 321,400円 | +14.3% | +26.5% | 1.87% | 25.16倍 | 3.69倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 683,000円 | +2.2% | +10.2% | 1.76% | 13.11倍 | 1.32倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,800円 | +5.7% | +3.9% | 2.38% | 11.98倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 398,300円 | +1.7% | -2.9% | 4.02% | 26.13倍 | 1.37倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム